{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:20:48Z","timestamp":1791991248024,"version":"4.4.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11864-020-00736-w","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T04:06:08Z","timestamp":1588219568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms"],"prefix":"10.1007","volume":"21","author":[{"given":"Valentina","family":"Andreasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Muffatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Guarneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Falconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Partelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"issue":"10","key":"736_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335\u201342.","journal-title":"JAMA Oncol"},{"issue":"9","key":"736_CR2","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1245\/s10434-013-3005-7","volume":"20","author":"EJ Kuo","year":"2013","unstructured":"Kuo EJ, Salem RR. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size. Ann Surg Oncol. 2013;20(9):2815\u201321.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"736_CR3","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/bjs.6051","volume":"95","author":"L. Fischer","year":"2008","unstructured":"Fischer L, Kleeff J, Esposito I, Hinz U, Zimmermann A, Friess H, et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg. 2008. https:\/\/doi.org\/10.1002\/bjs.6051.","journal-title":"British Journal of Surgery"},{"issue":"2","key":"736_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000443171","volume":"103","author":"M. Falconi","year":"2016","unstructured":"Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, Caplin M, et al. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology. 2016. https:\/\/doi.org\/10.1159\/000443171.","journal-title":"Neuroendocrinology"},{"issue":"2","key":"736_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000443171","volume":"103","author":"M Falconi","year":"2016","unstructured":"Falconi M, Eriksson B, Kaltsas G, Bartsch DK, Capdevila J, Caplin M, et al. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology. 2016;103(2):153\u201371.","journal-title":"Neuroendocrinology."},{"issue":"1","key":"736_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MPA.0000000000001454","volume":"49","author":"JR Howe","year":"2020","unstructured":"Howe JR, Merchant NB, Conrad C, Keutgen XM, Hallet J, Drebin JA, et al. The North American Neuroendocrine Tumor Society consensus paper on the surgical management of pancreatic neuroendocrine tumors. Pancreas. 2020;49(1):1\u201333.","journal-title":"Pancreas."},{"issue":"2","key":"736_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000499606","volume":"109","author":"Stefano Partelli","year":"2019","unstructured":"Partelli S, Giannone F, Schiavo Lena M, Muffatti F, Andreasi V, Crippa S, et al. Is the real prevalence of pancreatic neuroendocrine tumors underestimated? A retrospective study on a large series of pancreatic specimens. Neuroendocrinology. 2019. https:\/\/doi.org\/10.1159\/000499606.","journal-title":"Neuroendocrinology"},{"issue":"9","key":"736_CR8","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1245\/s10434-017-5946-8","volume":"24","author":"C Ricci","year":"2017","unstructured":"Ricci C, Casadei R, Taffurelli G, Pacilio CA, Campana D, Ambrosini V, et al. Sporadic small (<\/=20 mm) nonfunctioning pancreatic neuroendocrine neoplasm: is the risk of malignancy negligible when adopting a more conservative strategy? A systematic review and meta-analysis. Ann Surg Oncol. 2017 Sep;24(9):2603\u201310.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"736_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/bjs.10312","volume":"104","author":"S Partelli","year":"2017","unstructured":"Partelli S, Cirocchi R, Crippa S, Cardinali L, Fendrich V, Bartsch DK, et al. Systematic review of active surveillance versus surgical management of asymptomatic small non-functioning pancreatic neuroendocrine neoplasms. Br J Surg. 2017 Jan;104(1):34\u201341.","journal-title":"Br J Surg"},{"issue":"6","key":"736_CR10","doi-asserted-by":"publisher","first-page":"693","DOI":"10.6004\/jnccn.2018.0056","volume":"16","author":"Manisha H. Shah","year":"2018","unstructured":"Shah MH, Goldner WS, Halfdanarson TR, Bergsland E, Berlin JD, Halperin D, et al. NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018. J Natl Compr Cancer Netw. 2018 DOI: https:\/\/doi.org\/10.6004\/jnccn.2018.0056","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"736_CR11","doi-asserted-by":"publisher","unstructured":"Barenboim A, Lahat G, Nachmany I, Nakache R, Goykhman Y, Geva R, et al. Resection versus observation of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors. J Gastrointest Surg. 2019:1\u20139. https:\/\/doi.org\/10.1007\/s11605-019-04285-y.","DOI":"10.1007\/s11605-019-04285-y"},{"issue":"2","key":"736_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.surg.2019.04.003","volume":"166","author":"Stefano Partelli","year":"2019","unstructured":"\u2022 Partelli S, Mazza M, Andreasi V, Muffatti F, Crippa S, Tamburrino D, et al. Management of small asymptomatic nonfunctioning pancreatic neuroendocrine tumors: limitations to apply guidelines into real life. Surg (United States). 2019. https:\/\/doi.org\/10.1016\/j.surg.2019.04.003 Series showing the real-life management of patients with asymptomatic NF-PanNET \u22642 cm, highlighting the challenging situations in which guidelines are not applied.","journal-title":"Surgery"},{"key":"736_CR13","doi-asserted-by":"publisher","unstructured":"Assi HA, Mukherjee S, Kunz PL, Machiorlatti M, Vesely S, Pareek V, et al. Surgery versus surveillance for well-differentiated, nonfunctional pancreatic neuroendocrine tumors: an 11-year analysis of the National Cancer Database. Oncologist. 2019. https:\/\/doi.org\/10.1634\/theoncologist.2019-0466.","DOI":"10.1634\/theoncologist.2019-0466"},{"key":"736_CR14","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Powers BD, Rothermel LD, Fleming JB, Strosberg JR, Anaya DA. A survival analysis of patients with localized, asymptomatic pancreatic neuroendocrine tumors: no surgical survival benefit when examining appropriately selected outcomes. J Gastrointest Surg. 2019. https:\/\/doi.org\/10.1007\/s11605-019-04433-4 Series investigating the long-term outcomes of patients with asymptomatic NF-PanNET \u22642 cm managed with surgery or active surveillance.","DOI":"10.1007\/s11605-019-04433-4"},{"key":"736_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00268-018-4751-2","volume":"43","author":"I Mintziras","year":"2019","unstructured":"Mintziras I, Keck T, Werner J, Fichtner-Feigl S, Wittel U, Senninger N, et al. Implementation of current ENETS guidelines for surgery of small (\u22642 cm) pancreatic neuroendocrine neoplasms in the German surgical community: an analysis of the prospective DGAV StuDoQ|pancreas registry. World J Surg. 2019;43:175\u201382. https:\/\/doi.org\/10.1007\/s00268-018-4751-2.","journal-title":"World J Surg"},{"issue":"7","key":"736_CR16","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/jso.25716","volume":"120","author":"D-H Dong","year":"2019","unstructured":"Dong D-H, Zhang X-F, Poultsides G, Rocha F, Weber S, Fields R, et al. Impact of tumor size and nodal status on recurrence of nonfunctional pancreatic neuroendocrine tumors <\/=2 cm after curative resection: a multi-institutional study of 392 cases. J Surg Oncol. 2019 Dec;120(7):1071\u20139.","journal-title":"J Surg Oncol"},{"issue":"5","key":"736_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.dld.2019.01.008","volume":"51","author":"S Partelli","year":"2019","unstructured":"Partelli S, Muffatti F, Rancoita PMV, Andreasi V, Balzano G, Crippa S, et al. The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age. Dig Liver Dis. 2019 May;51(5):735\u201340.","journal-title":"Dig Liver Dis"},{"issue":"1","key":"736_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.surg.2019.03.008","volume":"166","author":"AG Lopez-Aguiar","year":"2019","unstructured":"Lopez-Aguiar AG, Ethun CG, Zaidi MY, Rocha FG, Poultsides GA, Dillhoff M, et al. The conundrum of < 2-cm pancreatic neuroendocrine tumors: a preoperative risk score to predict lymph node metastases and guide surgical management. Surgery. 2019 Jul;166(1):15\u201321.","journal-title":"Surgery."},{"key":"736_CR19","volume-title":"WHO classification of Tumours of endocrine organs","year":"2017","unstructured":"Lloyd RV, Osamura RY, Kloppel G, Rosai J, editors. WHO classification of Tumours of endocrine organs. 4th ed. Lyon: IARC Press; 2017.","edition":"4"},{"issue":"4","key":"736_CR20","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1097\/MPA.0000000000001273","volume":"48","author":"S Partelli","year":"2019","unstructured":"Partelli S, Tamburrino D, Cherif R, Muffatti F, Moggia E, Gaujoux S, et al. Risk and predictors of postoperative morbidity and mortality after pancreaticoduodenectomy for pancreatic neuroendocrine neoplasms: a comparative study with pancreatic ductal adenocarcinoma. Pancreas. 2019;48(4):504\u20139.","journal-title":"Pancreas."},{"issue":"3","key":"736_CR21","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/SLA.0000000000003022","volume":"271","author":"Antonio Pea","year":"2020","unstructured":"Pea A, Yu J, Marchionni L, Noe M, Luchini C, Pulvirenti A, et al. Genetic analysis of small well-differentiated pancreatic neuroendocrine tumors identifies subgroups with differing risks of liver metastases. Ann Surg. 2018. https:\/\/doi.org\/10.1097\/sla.0000000000003022.","journal-title":"Annals of Surgery"},{"issue":"1","key":"736_CR22","doi-asserted-by":"publisher","first-page":"18614","DOI":"10.1038\/s41598-019-55156-0","volume":"9","author":"M Cives","year":"2019","unstructured":"Cives M, Partelli S, Palmirotta R, Lovero D, Mandriani B, Quaresmini D, et al. DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors. Sci Rep. 2019;9(1):18614.","journal-title":"Sci Rep"},{"issue":"10","key":"736_CR23","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1001\/jamasurg.2013.3376","volume":"148","author":"Stefano Partelli","year":"2013","unstructured":"Partelli S, Gaujoux S, Boninsegna L, Cherif R, Crippa S, Couvelard A, et al. Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). JAMA Surg. 2013. https:\/\/doi.org\/10.1001\/jamasurg.2013.3376.","journal-title":"JAMA Surgery"},{"issue":"2","key":"736_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/SLA.0000000000000348","volume":"259","author":"YM Hashim","year":"2014","unstructured":"Hashim YM, Trinkaus KM, Linehan DC, Strasberg SS, Fields RC, Cao D, et al. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg. 2014;259(2):197\u2013203.","journal-title":"Ann Surg"},{"key":"736_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s11605-014-2624-z","volume":"19","author":"T Curran","year":"2014","unstructured":"Curran T, Pockaj BA, Gray RJ, Halfdanarson TR, Wasif N. Importance of lymph node involvement in pancreatic neuroendocrine tumors: impact on survival and implications for surgical resection. J Gastrointest Surg. 2014;19:152\u201360. https:\/\/doi.org\/10.1007\/s11605-014-2624-z.","journal-title":"J Gastrointest Surg"},{"issue":"3","key":"736_CR26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/SLA.0000000000003461","volume":"270","author":"Mohammad Y. Zaidi","year":"2019","unstructured":"Zaidi MY, Lopez-Aguiar AG, Switchenko JM, Lipscomb J, Andreasi V, Partelli S, et al. A novel validated recurrence risk score to guide a pragmatic surveillance strategy after resection of pancreatic neuroendocrine tumors: an international study of 1006 patients. Ann Surg. 2019. https:\/\/doi.org\/10.1097\/SLA.0000000000003461.","journal-title":"Annals of Surgery"},{"issue":"6","key":"736_CR27","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1097\/SLA.0000000000002123","volume":"267","author":"CG Genc","year":"2018","unstructured":"Genc CG, Jilesen AP, Partelli S, Falconi M, Muffatti F, van Kemenade FJ, et al. A new scoring system to predict recurrent disease in grade 1 and 2 nonfunctional pancreatic neuroendocrine tumors. Ann Surg. 2018 Jun;267(6):1148\u201354.","journal-title":"Ann Surg"},{"key":"736_CR28","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1245\/s10434-018-6518-2","volume":"25","author":"CG Gen\u00e7","year":"2018","unstructured":"Gen\u00e7 CG, Falconi M, Partelli S, Muffatti F, van Eeden S, Doglioni C, et al. Recurrence of pancreatic neuroendocrine tumors and survival predicted by Ki67. Ann Surg Oncol. 2018;25:2467\u201374. https:\/\/doi.org\/10.1245\/s10434-018-6518-2.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"736_CR29","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.ejso.2018.03.005","volume":"44","author":"Stefano Partelli","year":"2018","unstructured":"\u2022\u2022 Partelli S, Javed AA, Andreasi V, He J, Muffatti F, Weiss MJ, et al. The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms. Eur J Surg Oncol. 2018;44(6). https:\/\/doi.org\/10.1016\/j.ejso.2018.03.005 This series investigates the prognostic role of the number of positive lymph nodes in patients submitted to pancreaticoduodenectomy for NF-PanNEN and it proposes a minimum number of lymph nodes to be resected in order to guarantee an adequate nodal staging.","journal-title":"European Journal of Surgical Oncology"},{"key":"736_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6856329","volume":"2019","author":"G. Capretti","year":"2019","unstructured":"Capretti G, Nappo G, Smiroldo V, Cereda M, Branciforte B, Spaggiari P, et al. The number of metastatic lymph nodes is a useful predictive factor for recurrence after surgery for nonmetastatic nonfunctional neuroendocrine neoplasm of the pancreas. Gastroenterol Res Pract. 2019. https:\/\/doi.org\/10.1155\/2019\/6856329.","journal-title":"Gastroenterology Research and Practice"},{"key":"736_CR31","doi-asserted-by":"publisher","unstructured":"Zhang X-F, Xue F, Dong D-H, Lopez-Aguiar AG, Poultsides G, Makris E, et al. New nodal staging for primary pancreatic neuroendocrine tumors: a multi-institutional and National Data Analysis. Ann Surg. 2019 Jul. https:\/\/doi.org\/10.1097\/SLA.0000000000003478.","DOI":"10.1097\/SLA.0000000000003478"},{"issue":"7","key":"736_CR32","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/jso.25689","volume":"120","author":"L Wu","year":"2019","unstructured":"Wu L, Sahara K, Tsilimigras DI, Maithel SK, Poultsides GA, Rocha FG, et al. Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: a multi-institutional analysis. J Surg Oncol. 2019 Dec;120(7):1080\u20136.","journal-title":"J Surg Oncol"},{"issue":"9","key":"736_CR33","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1245\/s10434-019-07506-5","volume":"26","author":"R Mao","year":"2019","unstructured":"Mao R, Zhao H, Li K, Luo S, Turner M, Cai J-Q, et al. Outcomes of lymph node dissection for non-metastatic pancreatic neuroendocrine tumors: a propensity score-weighted analysis of the National Cancer Database. Ann Surg Oncol. 2019 Sep;26(9):2722\u20139.","journal-title":"Ann Surg Oncol"},{"key":"736_CR34","doi-asserted-by":"crossref","unstructured":"Izumo W, Higuchi R, Furukawa T, Yazawa T, Uemura S, Shiihara M, et al. Evaluation of the site and frequency of lymph node metastasis with non-functioning pancreatic neuroendocrine tumor. Eur Surg Res. 2019:1\u201310.","DOI":"10.1159\/000504410"},{"issue":"8","key":"736_CR35","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1245\/s10434-019-07367-y","volume":"26","author":"AG Lopez-Aguiar","year":"2019","unstructured":"\u2022\u2022 Lopez-Aguiar AG, Zaidi MY, Beal EW, Dillhoff M, JGD C, Poultsides GA, et al. Defining the role of lymphadenectomy for pancreatic neuroendocrine tumors: an eight-institution study of 695 patients from the US neuroendocrine tumor study group. Ann Surg Oncol. 2019;26(8):2517\u201324 This series investigates the prognostic role of the number of positive lymph nodes in patients submitted to distal pancreatectomy for NF-PanNEN and it proposes a minimum number of lymph nodes to be resected in order to guarantee an adequate nodal staging.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"736_CR36","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1245\/s10434-019-08120-1","volume":"27","author":"Kota Sahara","year":"2019","unstructured":"Sahara K, Tsilimigras DI, Mehta R, Moro A, Paredes AZ, Lopez-Aguiar AG, et al. Trends in the number of lymph nodes evaluated among patients with pancreatic neuroendocrine tumors in the United States: a multi-institutional and National Database Analysis. Ann Surg Oncol. 2019:1\u201310. https:\/\/doi.org\/10.1245\/s10434-019-08120-1.","journal-title":"Annals of Surgical Oncology"},{"issue":"4","key":"736_CR37","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.surg.2017.11.007","volume":"163","author":"Stefano Partelli","year":"2018","unstructured":"\u2022\u2022 Partelli S, Bertani E, Bartolomei M, Perali C, Muffatti F, Grana CM, et al. Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms. Surgery. 2018. https:\/\/doi.org\/10.1016\/j.surg.2017.11.007 Series investigating the role of neoadjuvant peptide receptor radionuclide therapy for those patients with resectable or potentially resectable PanNEN displaying features at high risk for recurrence.","journal-title":"Surgery"},{"issue":"2","key":"736_CR38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jso.25481","volume":"120","author":"X-F Zhang","year":"2019","unstructured":"Zhang X-F, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, et al. Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: an analysis from the U.S. neuroendocrine tumor study group. J Surg Oncol. 2019;120(2):231\u201340.","journal-title":"J Surg Oncol"},{"issue":"3","key":"736_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000464292","volume":"105","author":"S Partelli","year":"2017","unstructured":"Partelli S, Bartsch DK, Capdevila J, Chen J, Knigge U, Niederle B, et al. ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours. Neuroendocrinology. 2017;105(3):255\u201365.","journal-title":"Neuroendocrinology."},{"issue":"5","key":"736_CR40","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s11605-015-2788-1","volume":"19","author":"Dimitrios Xourafas","year":"2015","unstructured":"Xourafas D, Tavakkoli A, Clancy TE, Ashley SW. Distal pancreatic resection for neuroendocrine tumors: is laparoscopic really better than open? J Gastrointest Surg. 2015. https:\/\/doi.org\/10.1007\/s11605-015-2788-1.","journal-title":"Journal of Gastrointestinal Surgery"},{"key":"736_CR41","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s00464-017-5414-3","volume":"31","author":"B Edwin","year":"2017","unstructured":"Edwin B, Sahakyan MA, Abu Hilal M, Besselink MG, Braga M, Fabre JM, et al. Laparoscopic surgery for pancreatic neoplasms: the European association for endoscopic surgery clinical consensus conference. Surg Endosc. 2017;31:2023\u201341. https:\/\/doi.org\/10.1007\/s00464-017-5414-3.","journal-title":"Surg Endosc"},{"key":"736_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s13304-010-0027-6","volume":"62","author":"R Casadei","year":"2010","unstructured":"Casadei R, Ricci C, D\u2019Ambra M, Marrano N, Alagna V, Rega D, et al. Laparoscopic versus open distal pancreatectomy in pancreatic tumours: a case-control study. Updat Surg. 2010;62:171\u20134. https:\/\/doi.org\/10.1007\/s13304-010-0027-6.","journal-title":"Updat Surg"},{"issue":"1","key":"736_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/17474124.2017.1253473","volume":"11","author":"D Tamburrino","year":"2017","unstructured":"Tamburrino D, Partelli S, Renzi C, Crippa S, Muffatti F, Perali C, et al. Systematic review and meta-analysis on laparoscopic pancreatic resections for neuroendocrine neoplasms (PNENs). Expert Rev Gastroenterol Hepatol. 2017 Jan;11(1):65\u201373.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"5","key":"736_CR44","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/hpb.12162","volume":"16","author":"Panagiotis Drymousis","year":"2014","unstructured":"Drymousis P, Raptis DA, Spalding D, Fernandez-Cruz L, Menon D, Breitenstein S, et al. Laparoscopic versus open pancreas resection for pancreatic neuroendocrine tumours: a systematic review and meta-analysis. HPB. 2014. https:\/\/doi.org\/10.1111\/hpb.12162.","journal-title":"HPB"},{"key":"736_CR45","doi-asserted-by":"publisher","unstructured":"\u2022 Partelli S, Andreasi V, PMV R, Perez-Sanchez E, Muffatti F, Balzano G, et al. Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting. Surg Endosc. 2020. https:\/\/doi.org\/10.1007\/s00464-020-07375-0 Series comparing short-term and long-term outcomes in a very selected population of patients submitted to open or laparoscopic DP for NF-PanNEN, using a propensity score weighting to minimize selection bias.","DOI":"10.1007\/s00464-020-07375-0"},{"issue":"4","key":"736_CR46","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00423-019-01786-x","volume":"404","author":"S Alfieri","year":"2019","unstructured":"Alfieri S, Butturini G, Boggi U, Pietrabissa A, Morelli L, Vistoli F, et al. Short-term and long-term outcomes after robot-assisted versus laparoscopic distal pancreatectomy for pancreatic neuroendocrine tumors (pNETs): a multicenter comparative study. Langenbeck's Arch Surg. 2019 Jun;404(4):459\u201368.","journal-title":"Langenbeck's Arch Surg"},{"issue":"1","key":"736_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12893-017-0301-3","volume":"17","author":"GP Guerrini","year":"2017","unstructured":"Guerrini GP, Lauretta A, Belluco C, Olivieri M, Forlin M, Basso S, et al. Robotic versus laparoscopic distal pancreatectomy: an up-to-date meta-analysis. BMC Surg. 2017 Nov;17(1):105.","journal-title":"BMC Surg"},{"issue":"7","key":"736_CR48","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.hpb.2017.03.004","volume":"19","author":"AH Zureikat","year":"2017","unstructured":"Zureikat AH, Borrebach J, Pitt HA, Mcgill D, Hogg ME, Thompson V, et al. Minimally invasive hepatopancreatobiliary surgery in North America: an ACS-NSQIP analysis of predictors of conversion for laparoscopic and robotic pancreatectomy and hepatectomy. HPB (Oxford). 2017 Jul;19(7):595\u2013602.","journal-title":"HPB (Oxford)"},{"key":"736_CR49","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1245\/s10434-017-6062-5","volume":"24","author":"I Nassour","year":"2017","unstructured":"Nassour I, Wang SC, Porembka MR, Augustine MM, Yopp AC, Mansour JC, et al. Conversion of minimally invasive distal pancreatectomy: predictors and outcomes. Ann Surg Oncol. 2017;24:3725\u201331. https:\/\/doi.org\/10.1245\/s10434-017-6062-5.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"736_CR50","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3390\/jcm8101611","volume":"8","author":"Andreasi","year":"2019","unstructured":"Andreasi V, Partelli S, Capurso G, Muffatti F, Balzano G, Crippa S, et al. Long-term pancreatic functional impairment after surgery for neuroendocrine neoplasms. J Clin Med. 2019;8(10). https:\/\/doi.org\/10.3390\/jcm8101611.","journal-title":"Journal of Clinical Medicine"},{"issue":"9","key":"736_CR51","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1007\/s11605-008-0560-5","volume":"12","author":"Jonathan King","year":"2008","unstructured":"King J, Kazanjian K, Matsumoto J, Reber HA, Yeh MW, Hines OJ, et al. Distal pancreatectomy: incidence of postoperative diabetes. J Gastrointest Surg. 2008. https:\/\/doi.org\/10.1007\/s11605-008-0560-5.","journal-title":"Journal of Gastrointestinal Surgery"},{"issue":"4","key":"736_CR52","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.hpb.2015.11.003","volume":"18","author":"Pei-Wen Lim","year":"2016","unstructured":"Lim PW, Dinh KH, Sullivan M, Wassef WY, Zivny J, Whalen GF, et al. Thirty-day outcomes underestimate endocrine and exocrine insufficiency after pancreatic resection. HPB. 2016. https:\/\/doi.org\/10.1016\/j.hpb.2015.11.003.","journal-title":"HPB"},{"issue":"9","key":"736_CR53","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/bjs.9819","volume":"102","author":"FJ Huttner","year":"2015","unstructured":"Huttner FJ, Koessler-Ebs J, Hackert T, Ulrich A, Buchler MW, Diener MK. Meta-analysis of surgical outcome after enucleation versus standard resection for pancreatic neoplasms. Br J Surg. 2015 Aug;102(9):1026\u201336.","journal-title":"Br J Surg"},{"issue":"10","key":"736_CR54","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1007\/s00268-018-4628-4","volume":"42","author":"G Belfiori","year":"2018","unstructured":"Belfiori G, Wiese D, Partelli S, Wachter S, Maurer E, Crippa S, et al. Minimally invasive versus open treatment for benign sporadic insulinoma comparison of short-term and long-term outcomes. World J Surg. 2018 Oct;42(10):3223\u201330.","journal-title":"World J Surg"},{"issue":"1","key":"736_CR55","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.surg.2011.02.022","volume":"150","author":"R Bettini","year":"2011","unstructured":"Bettini R, Partelli S, Boninsegna L, Capelli P, Crippa S, Pederzoli P, et al. Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor. Surgery. 2011 Jul;150(1):75\u201382.","journal-title":"Surgery."},{"issue":"5","key":"736_CR56","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ejso.2018.11.021","volume":"45","author":"Salvatore Paiella","year":"2019","unstructured":"\u2022 Paiella S, De Pastena M, Faustini F, Landoni L, Pollini T, Bonamini D, et al. Central pancreatectomy for benign or low-grade malignant pancreatic lesions - a single-center retrospective analysis of 116 cases. Eur J Surg Oncol. 2019. https:\/\/doi.org\/10.1016\/j.ejso.2018.11.021 Series reporting the outcomes of central pancreatectomy in patients with benign or low-grade malignant leasions, of whom 89% were PanNEN.","journal-title":"European Journal of Surgical Oncology"},{"issue":"1","key":"736_CR57","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/S1470-2045(13)70362-0","volume":"15","author":"A Frilling","year":"2014","unstructured":"Frilling A, Modlin IM, Kidd M, Russell C, Breitenstein S, Salem R, et al. Recommendations for management of patients with neuroendocrine liver metastases. Lancet Oncol. 2014 Jan;15(1):e8\u201321.","journal-title":"Lancet Oncol"},{"issue":"2","key":"736_CR58","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000443167","volume":"103","author":"M Pavel","year":"2016","unstructured":"Pavel M, O\u2019Toole D, Costa F, Capdevila J, Gross D, Kianmanesh R, et al. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. 2016;103(2):172\u201385.","journal-title":"Neuroendocrinology."},{"issue":"1\u20132","key":"736_CR59","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1159\/000431379","volume":"102","author":"S Partelli","year":"2015","unstructured":"Partelli S, Inama M, Rinke A, Begum N, Valente R, Fendrich V, et al. Long-term outcomes of surgical management of pancreatic neuroendocrine tumors with synchronous liver metastases. Neuroendocrinology. 2015;102(1\u20132):68\u201376.","journal-title":"Neuroendocrinology."},{"issue":"2","key":"736_CR60","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ejso.2016.09.011","volume":"43","author":"E Bertani","year":"2017","unstructured":"Bertani E, Fazio N, Radice D, Zardini C, Spinoglio G, Chiappa A, et al. Assessing the role of primary tumour resection in patients with synchronous unresectable liver metastases from pancreatic neuroendocrine tumour of the body and tail. A propensity score survival evaluation. Eur J Surg Oncol. 2017 Feb;43(2):372\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"736_CR61","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ejso.2016.10.031","volume":"43","author":"D Citterio","year":"2017","unstructured":"Citterio D, Pusceddu S, Facciorusso A, Coppa J, Milione M, Buzzoni R, et al. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver. Eur J Surg Oncol. 2017 Feb;43(2):380\u20137.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"736_CR62","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.hpb.2017.10.014","volume":"20","author":"Stefano Partelli","year":"2018","unstructured":"\u2022 Partelli S, Cirocchi R, PMV R, Muffatti F, Andreasi V, Crippa S, et al. A systematic review and meta-analysis on the role of palliative primary resection for pancreatic neuroendocrine neoplasm with liver metastases. HPB. 2018;20(3). https:\/\/doi.org\/10.1016\/j.hpb.2017.10.014 Overview of the results of palliative primary resection for PanNEN with unresectable liver metastases.","journal-title":"HPB"},{"issue":"10","key":"736_CR63","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/j.ejso.2017.05.016","volume":"43","author":"LM Almond","year":"2017","unstructured":"Almond LM, Hodson J, Ford SJ, Gourevitch D, Roberts KJ, Shah T, et al. Role of palliative resection of the primary tumour in advanced pancreatic and small intestinal neuroendocrine tumours: a systematic review and meta-analysis. Eur J Surg Oncol. 2017 Oct;43(10):1808\u201315.","journal-title":"Eur J Surg Oncol"},{"key":"736_CR64","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jss.2019.04.002","volume":"243","author":"H Ye","year":"2019","unstructured":"Ye H, Xu HL, Shen Q, Zheng Q, Chen P. Palliative resection of primary tumor in metastatic nonfunctioning pancreatic neuroendocrine tumors. J Surg Res. 2019 Nov;243:578\u201387.","journal-title":"J Surg Res"},{"key":"736_CR65","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.2147\/CIA.S209428","volume":"14","author":"J Zhang","year":"2019","unstructured":"Zhang J, Peng C-S, Tian Y-H. Primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor: to do or not to do? Clin Interv Aging. 2019;14:1419\u201332.","journal-title":"Clin Interv Aging"},{"issue":"3","key":"736_CR66","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.surg.2018.09.006","volume":"165","author":"JF Tierney","year":"2019","unstructured":"Tierney JF, Chivukula SV, Wang X, Pappas SG, Schadde E, Hertl M, et al. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery. 2019 Mar;165(3):644\u201351.","journal-title":"Surgery."},{"key":"736_CR67","first-page":"5867","volume":"15","author":"D Kaemmerer","year":"2019","unstructured":"Kaemmerer D, Twrznik M, Kulkarni HR, H\u00f6rsch D, Sehner S, Baum RP, et al. Prior resection of the primary tumor prolongs survival after peptide receptor radionuclide therapy of advanced neuroendocrine neoplasms. Ann Surg. 2019;15:5867\u201370.","journal-title":"Ann Surg"},{"key":"736_CR68","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1245\/s10434-016-5550-3","volume":"23","author":"E Bertani","year":"2016","unstructured":"Bertani E, Fazio N, Radice D, Zardini C, Grana C, Bodei L, et al. Resection of the primary tumor followed by peptide receptor radionuclide therapy as upfront strategy for the treatment of G1\u2013G2 pancreatic neuroendocrine tumors with unresectable liver metastases. Ann Surg Oncol. 2016;23:981\u20139. https:\/\/doi.org\/10.1245\/s10434-016-5550-3.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"736_CR69","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1245\/s10434-010-1154-5","volume":"17","author":"SC Mayo","year":"2010","unstructured":"Mayo SC, de Jong MC, Pulitano C, Clary BM, Reddy SK, Gamblin TC, et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol. 2010 Dec;17(12):3129\u201336.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"736_CR70","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.hpb.2017.08.039","volume":"20","author":"A Ejaz","year":"2018","unstructured":"Ejaz A, Reames BN, Maithel S, Poultsides GA, Bauer TW, Fields RC, et al. Cytoreductive debulking surgery among patients with neuroendocrine liver metastasis: a multi-institutional analysis. HPB (Oxford). 2018 Mar;20(3):277\u201384.","journal-title":"HPB (Oxford)"},{"issue":"1","key":"736_CR71","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1072-7515(03)00230-8","volume":"197","author":"JM Sarmiento","year":"2003","unstructured":"Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003 Jul;197(1):29\u201337.","journal-title":"J Am Coll Surg"},{"issue":"6","key":"736_CR72","first-page":"1091","volume":"108","author":"GP McEntee","year":"1990","unstructured":"McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery. 1990;108(6):1091\u20136.","journal-title":"Surgery."},{"issue":"4","key":"736_CR73","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.surg.2008.06.008","volume":"144","author":"AJ Chambers","year":"2008","unstructured":"Chambers AJ, Pasieka JL, Dixon E, Rorstad O. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors. Surgery. 2008;144(4):643\u20135.","journal-title":"Surgery."},{"issue":"1","key":"736_CR74","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.surg.2015.05.040","volume":"159","author":"JE Maxwell","year":"2016","unstructured":"Maxwell JE, Sherman SK, O\u2019Dorisio TM, Bellizzi AM, Howe JR. Liver-directed surgery of neuroendocrine metastases: what is the optimal strategy? Surgery. 2016;159(1):320\u201333.","journal-title":"Surgery."},{"issue":"1","key":"736_CR75","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.surg.2017.05.030","volume":"163","author":"Rosemary E. Morgan","year":"2018","unstructured":"\u2022 Morgan RE, Pommier SJ, Pommier RF. Expanded criteria for debulking of liver metastasis also apply to pancreatic neuroendocrine tumors. Surgery. 2018;163(1):218\u201325 Series investigating oncological outcomes based on the percent of liver debulking.","journal-title":"Surgery"},{"issue":"4","key":"736_CR76","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1530\/ERC-18-0462","volume":"26","author":"Taymeyah Al-Toubah","year":"2019","unstructured":"\u2022\u2022 Al-Toubah T, Partelli S, Cives M, Andreasi V, Silvestris F, Falconi M, et al. Local treatment for focal progression in metastatic neuroendocrine tumors. Endocr Relat Cancer. 2018. https:\/\/doi.org\/10.1530\/ERC-18-0462 Series investigating the role of local treatments in focal disease progression, highlighting that this management enabled patients to remain on their existing systemic treatment.","journal-title":"Endocrine-Related Cancer"},{"issue":"3","key":"736_CR77","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000473892","volume":"105","author":"R Garcia-Carbonero","year":"2017","unstructured":"Garcia-Carbonero R, Rinke A, Valle JW, Fazio N, Caplin M, Gorbounova V, et al. ENETS consensus guidelines for the standards of care in neuroendocrine neoplasms. Systemic therapy 2: chemotherapy. Neuroendocrinology. 2017;105(3):281\u201394.","journal-title":"Neuroendocrinology."},{"issue":"6","key":"736_CR78","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/MPA.0b013e3181ebb56f","volume":"39","author":"JR Strosberg","year":"2010","unstructured":"Strosberg JR, Coppola D, Klimstra DS, Phan AT, Kulke MH, Wiseman GA, et al. The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. Pancreas. 2010 Aug;39(6):799\u2013800.","journal-title":"Pancreas."},{"issue":"3","key":"736_CR79","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.surg.2015.09.012","volume":"159","author":"S Crippa","year":"2016","unstructured":"Crippa S, Partelli S, Bassi C, Berardi R, Capelli P, Scarpa A, et al. Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: morphology matters. Surgery. 2016 Mar;159(3):862\u201371.","journal-title":"Surgery."},{"issue":"5","key":"736_CR80","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1245\/s10434-015-5013-2","volume":"23","author":"S-P Haugvik","year":"2016","unstructured":"Haugvik S-P, Janson ET, Osterlund P, Langer SW, Falk RS, Labori KJ, et al. Surgical treatment as a principle for patients with high-grade pancreatic neuroendocrine carcinoma: a Nordic multicenter comparative study. Ann Surg Oncol. 2016 May;23(5):1721\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"736_CR81","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1245\/s10434-019-08049-5","volume":"27","author":"Elettra Merola","year":"2019","unstructured":"\u2022 Merola E, Rinke A, Partelli S, Gress TM, Andreasi V, Koll\u00e1r A, et al. Surgery with radical intent: is there an indication for G3 neuroendocrine neoplasms? Ann Surg Oncol. 2019. https:\/\/doi.org\/10.1245\/s10434-019-08049-5 Series investigating the role of radical surgery in localized GEP-NEN G3.","journal-title":"Annals of Surgical Oncology"},{"issue":"5","key":"736_CR82","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1245\/s10434-019-07252-8","volume":"26","author":"Tsukasa Yoshida","year":"2019","unstructured":"\u2022\u2022 Yoshida T, Hijioka S, Hosoda W, Ueno M, Furukawa M, Kobayashi N, et al. Surgery for pancreatic neuroendocrine tumor G3 and carcinoma G3 should be considered separately. Ann Surg Oncol. 2019. https:\/\/doi.org\/10.1245\/s10434-019-07252-8 Series investigating the role of surgery in PanNEN G3, distinguishing between PanNET-G3 and PanNEC-G3, with and without distant metastases.","journal-title":"Annals of Surgical Oncology"},{"issue":"10","key":"736_CR83","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1210\/jc.2017-00372","volume":"102","author":"CRC Pieterman","year":"2017","unstructured":"Pieterman CRC, de Laat JM, Twisk JWR, van Leeuwaarde RS, de Herder WW, Dreijerink KMA, et al. Long-term natural course of small nonfunctional pancreatic neuroendocrine tumors in MEN1-results from the Dutch MEN1 study group. J Clin Endocrinol Metab. 2017 Oct;102(10):3795\u2013805.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"736_CR84","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s00268-005-0354-9","volume":"30","author":"F Triponez","year":"2006","unstructured":"Triponez F, Goudet P, Dosseh D, Cougard P, Bauters C, Murat A, et al. Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE. World J Surg. 2006 May;30(5):654.","journal-title":"World J Surg"},{"issue":"6","key":"736_CR85","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1159\/000443613","volume":"103","author":"S Partelli","year":"2016","unstructured":"Partelli S, Tamburrino D, Lopez C, Albers M, Milanetto AC, Pasquali C, et al. Active surveillance versus surgery of nonfunctioning pancreatic neuroendocrine neoplasms <\/=2 cm in MEN1 patients. Neuroendocrinology. 2016;103(6):779\u201386.","journal-title":"Neuroendocrinology."},{"issue":"6","key":"736_CR86","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1097\/SLA.0000000000002183","volume":"267","author":"S Nell","year":"2018","unstructured":"Nell S, Verkooijen HM, Pieterman CRC, de Herder WW, Hermus AR, Dekkers OM, et al. Management of MEN1 related nonfunctioning pancreatic NETs: a shifting paradigm: results from the DutchMEN1 study group. Ann Surg. 2018 Jun;267(6):1155\u201360.","journal-title":"Ann Surg"},{"issue":"1","key":"736_CR87","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/SLA.0000000000002191","volume":"268","author":"F Triponez","year":"2018","unstructured":"\u2022\u2022 Triponez F, Sadowski SM, Pattou F, Cardot-Bauters C, Mirallie E, Le Bras M, et al. Long-term follow-up of MEN1 patients who do not have initial surgery for small <\/=2 cm nonfunctioning pancreatic neuroendocrine tumorS, an AFCE and GTE study: Association Francophone de Chirurgie Endocrinienne & Groupe d\u2019Etude des Tumeurs Endocrines. Ann Surg. 2018;268(1):158\u201364 Series reporting the long-term outcomes of 46 patients with MEN1-associated NF-PanNEN \u2264 2 cm followed up for almost 11 years.","journal-title":"Ann Surg"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-020-00736-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-020-00736-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-020-00736-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T13:31:42Z","timestamp":1696080702000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-020-00736-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":87,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["736"],"URL":"https:\/\/doi.org\/10.1007\/s11864-020-00736-w","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"assertion":[{"value":"30 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"48"}}